Riskpilot← Back to searchSign inGet full accessDerma Hälsa Sweden AB
ABActiveOrg 5590773106Drottninggatan 97 Lgh 1301Medical specialists activities · NACE 8622Est. 20162 employees
Revenue 2025
SEK 8,3M
+10% vs 2024
EBITDA margin
75.6%
+14% vs 2024
Equity ratio
81.4%
Financial strength
Net profit 2025
SEK 5M
+13% vs 2024
| Revenue | SEK 8,3M | +10% |
| EBITDA | SEK 6,3M | +14% |
| Net profit | SEK 5M | +13% |
| Total assets | SEK 6,2M | +13% |
| Equity | SEK 5M | +13% |
| Employees | 2 | — |
Legal name
Derma Hälsa Sweden AB
Org number
5590773106
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
22 september 2016
Share capital
SEK 50 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-09-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva sjuk- och hälsovård samt därmed förenlig verksamhet.
Address
Drottninggatan 97 Lgh 1301
Email
torarian@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 4 759 | 6 948 | 7 403 | 7 590 | 8 318 |
| Staff expenses | — | −2 001 | −1 685 | −1 929 | −1 885 |
| EBITDA | 3 418 | 4 819 | 5 533 | 5 515 | 6 292 |
| Depreciation & amort. | −0 | — | — | −36 | −36 |
| EBIT | 3 418 | 4 819 | 5 533 | 5 479 | 6 256 |
| Net financials | −4 | −1 | −1 | 65 | 18 |
| Profit before tax | 3 414 | 4 817 | 5 532 | 5 544 | 6 274 |
| Tax | −733 | −993 | −1 141 | −1 144 | −1 293 |
| Net profit | 2 681 | 3 824 | 4 392 | 4 400 | 4 981 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 5 494 | 8 634 | 5 705 | 5 483 | 6 189 |
| Equity | 4 315 | 7 409 | 4 459 | 4 459 | 5 040 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 1 179 | 1 224 | 1 246 | 1 025 | 1 149 |
| Total debt | 1 179 | 1 224 | 1 246 | 1 025 | 1 149 |
EBITDA margin
75.6%
This company
15.8%
Market median
+378% vs market
20212025
Equity ratio
81.4%
This company
38.2%
Market median
+113% vs market
20212025
Return on equity
98.8%
This company
18.4%
Market median
+437% vs market
20212025
Net profit margin
59.9%
This company
8.1%
Market median
+640% vs market
20212025
Asset turnover
1.34×
This company
1.12×
Market median
+20% vs market
20212025
Debt / equity
0.23×
This company
0.62×
Market median
+63% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-10-01 – 2025-09-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-10-01 – 2024-09-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-10-01 – 2023-09-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-10-01 – 2022-09-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-10-01 – 2021-09-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Audit | 2025 | |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Derma Hälsa Sweden AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ben Behnam Mahajerzadeh-Heidari | Audit | 0 companies |
| Angela Khadeja Arian | Deputy Board Member | 0 companies |
| Mariam Torpikay Arian | Board of Directors | 0 companies |